Stealth’s Elamipretide: Is A New Preapproval Trial Feasible?

 
• By Sue Sutter
  
Trash out the window
One adcomm member said approving elamipretide now would be throwing away the opportunity for future studies. • Source: Shutterstock

More from Rare Diseases

More from US Advisory Committees